Publisher Correction: RUNX2 inhibitor CADD522 improves bone microarchitecture and lipid metabolism in post-menopausal bone loss.
Overview & Synopsis
Open access biomedical research article published in NPJ Drug Discov.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Publisher Correction: RUNX2 inhibitor CADD522 improves bone microarchitecture and lipid metabolism in post-menopausal bone loss. |
|---|---|
| Author / Organization | Ersek A, Kim MS, Suelzu C, Piec I, Matsangos A, Nurmemmedov E, Bull EC, Bartlett T, Dunn R, Dick JR, Lapidus R, Copeman DM, Tang JCY, Crichton PG, Pontifex MG, Fraser WD, Horwood NJ, Passaniti A, Green D |
| Subject & Discipline | NPJ Drug Discov |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-36309 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |